Varicella
📧 Sign up to get email alerts when something new happens for Varicella.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-06-02Clinical Trial Update: A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers [Phase 3]
A Phase 3 study evaluated two doses of Menactra meningococcal conjugate vaccine in healthy toddlers. The trial is completed and results were…
-
CLINICAL_TRIALS trial_result · 2011-04-21Clinical Trial Update: Study to Test the Safety and Immunogenicity of VARIVAX (2007 Process) (Study V210-057) (Completed) [Phase 3]
A Phase 3 trial evaluating the safety and immunogenicity of the Varivax varicella vaccine (2007 process) completed. Results were posted in 2…
-
CLINICAL_TRIALS trial_result · 2011-03-01Clinical Trial Update: Comparison of Brovavir Versus Acyclovir in the Treatment of Herpes in HIV-Infected Patients [Phase 2]
Phase 2 randomized trial comparing Brovavir to Acyclovir for herpes in HIV-infected patients has completed.
-
CLINICAL_TRIALS trial_result · 2010-08-27Clinical Trial Update: Immune Responses to Two Dose Varivax +/- MMR-II [Phase 1, Phase 2]
A Phase 1/2 clinical trial assessing immune responses to two doses of Varivax with or without MMR-II in measles, mumps, rubella, and varicel…
-
CLINICAL_TRIALS trial_result · 2010-08-27Clinical Trial Update: Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella Vaccines
The trial update describes immune responses of premature infants to the Measles-Mumps-Rubella (MMR) and Varicella vaccines, with the study s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-08-26Clinical Trial Update: Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age [Phase 2]
Phase 2 trial comparing MMRV vaccine from GlaxoSmithKline to ProQuad in children 12-14 months, assessing immunogenicity and safety for varic…
-
FDA approval · 2010-05-24FDA Approved: VALACYCLOVIR HYDROCHLORIDE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved the original application for valacyclovir hydrochloride (valacyclovir) by Mylan Pharmaceuticals Inc., a generic antiviral. The …
-
FDA approval · 2010-05-24FDA Approved: VALACYCLOVIR HYDROCHLORIDE — Original Application (TIME CAP LABORATORIES, INC.)
FDA approved Valacyclovir hydrochloride from Time Cap Laboratories under an Original Abbreviated New Drug Application.
-
FDA approval · 2010-04-19FDA Approved: VALTREX — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Valtrex (valacyclovir hydrochloride) submitted by GlaxoSmithKline LLC.
-
CLINICAL_TRIALS trial_result · 2010-02-25Clinical Trial Update: Frozen ProQuad Administered Concomitantly Versus Nonconcomitantly With Other Pediatric Vaccines [Phase 3]
A Phase 3 study evaluated administering Frozen ProQuad concurrently with other pediatric vaccines versus separately, with results posted Feb…
-
CLINICAL_TRIALS trial_result · 2010-02-15Clinical Trial Update: ProQuad Dose Selection Study (V221-011)(COMPLETED) [Phase 2]
A Phase 2 dose-selection study of ProQuad evaluated different dosing regimens to determine the optimal dose for protection against measles, …
-
CLINICAL_TRIALS trial_result · 2010-02-10Clinical Trial Update: ProQuad™ Versus M-M-R II™ and VARIVAX™ in Healthy Children (V221-009)(COMPLETED) [Phase 3]
Phase 3 trial comparing ProQuad (MMRV) with separate M-M-R II (MMR) and VARIVAX (varicella) vaccines in healthy children; the study is compl…
-
CLINICAL_TRIALS trial_result · 2010-02-10Clinical Trial Update: V221 Concomitant Use Study With Pneumococcal Conjugate Vaccine (V221-019) [Phase 3]
Phase 3 clinical trial update reporting results for V221-019, a concomitant-use study with Pneumococcal Conjugate Vaccine sponsored by Merck…
-
CLINICAL_TRIALS trial_result · 2010-02-09Clinical Trial Update: Safety, Tolerability, and Immunogenicity of 3 Frozen ProQuad Consistency Lots in Healthy Children (V221-012)(COMPLETED) [Phase 3]
This Phase 3 clinical trial evaluated safety, tolerability, and immunogenicity across three frozen ProQuad lot consistency lots in healthy c…
-
CLINICAL_TRIALS trial_result · 2010-01-29Clinical Trial Update: A Study of ProQuad in Healthy 4 to 6 Year Old Children (V221-014) [Phase 3]
Phase 3 trial of ProQuad in healthy children completed; results posted in 2010.
-
FDA approval · 2009-12-07FDA Approved: ACYCLOVIR — Supplemental Application (Aurobindo Pharma Limited)
FDA approves a supplemental application for acyclovir from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2009-07-03Clinical Trial Update: A Study to Evaluate Safety, Tolerability, and Immunogenicity of an Investigational Zoster Vaccine In Subjects With a History of Varicella (Chickenpox)(V211-010)(COMPLETED) [Phase 3]
A Phase 3 trial completed to assess safety, tolerability, and immunogenicity of an investigational zoster vaccine in adults with a history o…
-
CLINICAL_TRIALS trial_result · 2009-06-23Clinical Trial Update: Serological Evaluation of Varicella and Hepatitis A Vaccines Using Injector Delivery [Phase 2, Phase 3]
The document reports on ongoing Phase 2 and Phase 3 trials evaluating serological responses to Varicella and Hepatitis A vaccines delivered …
-
CLINICAL_TRIALS trial_result · 2008-11-20Clinical Trial Update: Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED) [Phase 4]
A Phase 4 safety study evaluating Merck's Hepatitis A inactivated vaccine and Measles, Mumps, Rubella and Varicella Live vaccine (ProQuad) h…
-
CLINICAL_TRIALS trial_result · 2008-10-13Clinical Trial Update: Immunogenicity/Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA): Using Two Different Administration Routes [Phase 3]
Phase 3 trial evaluating immunogenicity and safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA) using two administration routes; …
-
CLINICAL_TRIALS trial_result · 2008-02-08Clinical Trial Update: Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (FluMist) and Measles, Mumps, Rubella, and Varicella Vaccines Administered Concurrently to Healthy Children [Phase 3]
A Phase 3 trial evaluated safety, tolerability, and immunogenicity when FluMist and MMRV vaccines were administered concurrently to healthy …
-
CLINICAL_TRIALS trial_result · 2007-10-02Clinical Trial Update: A Study of BV-araU in the Treatment of Varicella-Zoster Viral Disease (VZV) in HIV-Infected Children Who Have Not Had Success With or Who Cannot Take Other Treatments for VZV [Phase 3]
This Phase 3 trial completed evaluating BV-araU for Varicella-Zoster Virus disease (chickenpox) in HIV-infected children who have not had su…
-
CLINICAL_TRIALS trial_result · 2007-09-26Clinical Trial Update: Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infection [Phase 3]
This update reports the completion of a Phase 3 trial evaluating the oral pediatric formulation of famciclovir in children aged 1-12 years w…
-
FDA approval · 2007-08-24FDA Approved: FAMCICLOVIR — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's generic famciclovir (Original Application). This approval expands access to an antiviral for the treatment of herpes zos…
-
FDA approval · 2007-01-31FDA Approved: VALACYCLOVIR — Original Application (SUN PHARMACEUTICAL INDUSTRIES, INC.)
FDA approved Sun Pharmaceutical Industries' original-application generic valacyclovir (valacyclovir), authorizing its marketing as an antivi…